Heritage Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$773K Sell
3,381
-438
-11% -$99.8K 0.06% 55
2025
Q3
$884K Buy
3,819
+446
+13% +$90.8K 0.08% 48
2025
Q2
$626K Sell
3,373
-310
-8% -$57.6K 0.06% 58
2025
Q1
$772K Buy
3,683
+142
+4% +$27.6K 0.08% 50
2024
Q4
$629K Buy
3,541
+148
+4% +$27.2K 0.08% 54
2024
Q3
$670K Buy
3,393
+350
+12% +$65.3K 0.09% 49
2024
Q2
$522K Sell
3,043
-69
-2% -$11.4K 0.07% 58
2024
Q1
$567K Sell
3,112
-47
-1% -$8.1K 0.08% 55
2023
Q4
$490K Buy
3,159
+228
+8% +$33.2K 0.08% 61
2023
Q3
$437K Buy
2,931
+215
+8% +$31.6K 0.09% 52
2023
Q2
$366K Buy
2,716
+38
+1% +$5.57K 0.07% 57
2023
Q1
$427K Sell
2,678
-133
-5% -$20.3K 0.09% 51
2022
Q4
$454K Buy
2,811
+582
+26% +$89.2K 0.12% 49
2022
Q3
$299K Buy
2,229
+121
+6% +$17.4K 0.18% 45
2022
Q2
$322K Sell
2,108
-489
-19% -$74.7K 0.18% 43
2022
Q1
$420K Buy
2,597
+395
+18% +$57.4K 0.27% 45
2021
Q4
$298K Buy
+2,202
New +$260K 0.23% 61

Other funds holding ABBV

Heritage Financial Services's ABBV Position: Q4 2025 in Review

Heritage Financial Services reduced its AbbVie (ABBV) stake by 11% in Q4 2025, selling an estimated $99.8K and leaving 3,381 shares worth $773K. The position accounts for 0.06% of the portfolio, ranked #55.

Heritage Financial Services first reported a position in ABBV in Q4 2021 and has held it in 17 quarters since. The position peaked at $884K in Q3 2025. 4,148 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Heritage Financial Services held 3,381 shares of AbbVie worth $773K as of Q4 2025.
  • Heritage Financial Services sold 438 AbbVie shares in Q4 2025, an estimated $99.8K.
  • AbbVie made up 0.06% of Heritage Financial Services's portfolio in Q4 2025, its #55 holding.
  • Heritage Financial Services first reported a position in AbbVie in Q4 2021 and has held it in 17 quarters since.
  • Heritage Financial Services's AbbVie position peaked at $884K in Q3 2025.
  • 4,148 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Heritage Financial Services's 13F filing for Q4 2025, filed 2 Feb 2026.